| Literature DB >> 34103632 |
Simona M Miron1,2, Ariane de Espindola1,2, Patrick Dutournié3,4, Arnaud Ponche1,2.
Abstract
During the processing of biomolecules by ultrafiltration, the lysozyme enzyme undergoes conformational changes, which can affect its antibacterial activity. Operational conditions are considered to be one of the main parameters responsible for such changes, especially when using the same membrane and molecule. The present study demonstrates that, the same cut-off membrane (commercial data) can result in different properties of the protein after filtration, due to their different pore network. The filtration of lysozyme, regardless of the membrane, produces a decrease in the membrane hydraulic permeability (between 10 and 30%) and an increase in its selectivity in terms of observed rejection rate (30%). For the filtrated lysozyme, it appears that the HPLC retention time increases depending on the membrane used. The antibacterial activity of the filtrated samples is lower than the native protein and decreases with the increase of the applied pressure reaching 55-60% loss for 12 bar which has not been reported in the literature before. The observed results by SEC-HPLC and bacteriological tests, suggest that the conformation of the filtrated molecules are indeed modified. These results highlight the relationship between protein conformation or activity and the imposed shear stress.Entities:
Year: 2021 PMID: 34103632 PMCID: PMC8187345 DOI: 10.1038/s41598-021-91564-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Basic information on the compounds used in the filtration experiments.
| Compound | Molecular formula | Molar mass (g mol−1) | Stokes radius (nm) | Concentration (mol L−1) |
|---|---|---|---|---|
| Vitamin B12 | 1355.38 | 0.7 | 9.22 × 10–6 | |
| Lysozyme | – | 14,300 | 1.9 | 0.025 × 10–3 |
Figure 1Initial membrane performances: hydraulic permeability Lp (point) and selectivity (columns) for the studied membranes (TAMI membranes, commercial cut-off 1 kDa).
Figure 2Normalized chromatograms of permeate samples (left) and population distribution (right) for M1 membrane.
Figure 3Normalized chromatograms of permeate samples (left) and population distribution (right) for M1Reg and/or M2Reg membranes.
Figure 4Lysozyme antibacterial activity for retentate (black) and permeate (red) solutions for (a) raw (M1 and M2) and (b) M1Reg and M2Reg; § represents the significant difference for P < 0.05 with respect to lysozyme reference (untreated lysozyme), blue line represents the lysozyme reference.
Figure 5Lysozyme antibacterial activity for retentate (black) and permeate (red) solutions for lower cut-off membrane M3; § represents the significant difference for P < 0.05 with respect to lysozyme reference (untreated lysozyme), blue line represents the lysozyme reference.